Diannexin protects against renal ischemia reperfusion injury and targets phosphatidylserines in ischemic tissue

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Wever, Kimberley E ^a   Wagener, Frank A D T G ^a   Frielink, Cathelijne ^a   Boerman, Otto C ^a   Scheffer, Gert J ^a   Allison, Anthony ^b   Masereeuw, Rosalinde ^a   Rongen, Gerard A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Alavita Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIANNEXIN; GLUCOSE; HOMODIMER; KIDNEY INJURY MOLECULE 1; LIPOCORTIN 5; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PHOSPHATIDYLSERINE; TECHNETIUM 99M; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL TRANSPORT; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG TARGETING; DRUG TISSUE LEVEL; DRUG UPTAKE; ENZYME LOCALIZATION; GLUCOSE BLOOD LEVEL; IN VIVO STUDY; ISOTOPE LABELING; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TUBULE DAMAGE; LEG EXERCISE; LEG ISCHEMIA; MALE; MICTURITION; MOUSE; NONHUMAN; PLASMA HALF LIFE; PROTEIN EXPRESSION; PROTEIN TARGETING; RENAL DIABETES; RENAL PROTECTION; REPERFUSION INJURY; TRANSCRIPTION REGULATION; UREA BLOOD LEVEL; ANIMAL; DRUG EFFECT; KIDNEY; METABOLISM;

ANIMALS; ANNEXIN A5; KIDNEY; MALE; MICE; PHOSPHATIDYLSERINES; REPERFUSION INJURY;

EID: 80052285990     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024276     Document Type: Article

References (39)

1. Granger DN, (1999) Ischemia-reperfusion: mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease. Microcirculation. 6: 167-78 (New York, N.Y.: 1994). Available:http://www.ncbi.nlm.nih.gov/pubmed/10501090. Accessed 11 Aug 2011.
2. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL, (1997) Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 63: 968-74.
3. Nigwekar SU, Kandula P, Hix JK, Thakar CV, (2009) Off-pump coronary artery bypass surgery and acute kidney injury: a meta-analysis of randomized and observational studies. American journal of kidney diseases: the official journal of the National Kidney Foundation 54: 413-23 doi:10.1053/j.ajkd.2009.01.267.
4. Safian RD, Textor SC, (2001) Renal-artery stenosis. The New England journal of medicine 344: 431-42.
5. Schrier RW, Wang W, (2004) Acute renal failure and sepsis. The New England journal of medicine 351: 159-69 doi:10.1056/NEJMra032401.
6. Kellum JA, (2008) Acute kidney injury. Critical care medicine 36: S141-5 doi:10.1097/CCM.0b013e318168c4a4.
7. Bonventre JV, Zuk A, (2004) Ischemic acute renal failure: an inflammatory disease? Kidney Int 66: 480-485.
8. Legrand M, Mik EG, Johannes T, Payen D, Ince C, (2008) Renal hypoxia and dysoxia after reperfusion of the ischemic kidney. Mol Med 14: 502-516.
9. Hofstra L, Liem IH, Dumont EA, Boersma HH, Heerde WLV, et al. (2000) Visualisation of cell death in vivo in patients with acute myocardial infarction. The Lancet 356: 209-212 doi:10.1016/S0140-6736(00)02482-X.
10. Rongen GA, Oyen WJG, Ramakers BP, Riksen NP, Boerman OC, et al. (2005) Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation 111: 173-8 doi:10.1161/01.CIR.0000151612.02223.F2.
11. Wolf A, Schmitz C, Bottger A, (2007) Changing story of the receptor for phosphatidylserine-dependent clearance of apoptotic cells. EMBO Rep 8: 465-469.
12. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, et al. (2002) Identification of a factor that links apoptotic cells to phagocytes. Nature 417: 182-7 Available:http://www.ncbi.nlm.nih.gov/pubmed/12000961. Accessed 9 May 2011.
13. Lentz B, (2003) Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Progress in Lipid Research 42: 423-438 doi:10.1016/S0163-7827(03)00025-0.
14. Mold C, Morris CA, (2001) Complement activation by apoptotic endothelial cells following hypoxia/reoxygenation. Immunology 102: 359-64.
15. Ysebaert DK, De GreefKE, De BeufA, Van RompayAR, Vercauteren S, et al. (2004) T cells as mediators in renal ischemia/reperfusion injury. Kidney Int 66: 491-496.
16. Tait JF, Gibson D, (1992) Phospholipid binding of annexin V: effects of calcium and membrane phosphatidylserine content. Archives of biochemistry and biophysics 298: 187-91.
17. Andree HA, Reutelingsperger CP, Hauptmann R, Hemker HC, Hermens WT, et al. (1990) Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. The Journal of biological chemistry 265: 4923-8.
18. Oling F, Bergsma-Schutter W, Brisson A, (2001) Trimers, dimers of trimers, and trimers of trimers are common building blocks of annexin a5 two-dimensional crystals. J Struct Biol 133: 55-63 Available:http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11356064.
19. Thiagarajan P, Benedict CR, (1997) Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model. Circulation 96: 2339-2347.
20. Qu J, Conroy LA, Walker JH, Wooding FB, Lucy JA, (1996) Phosphatidylserine-mediated adhesion of T-cells to endothelial cells. Biochem J 3172 (Pt 2): 343-346.
21. Kuypers FA, Larkin SK, Emeis JJ, Allison AC, (2007) Interaction of an annexin V homodimer (Diannexin) with phosphatidylserine on cell surfaces and consequent antithrombotic activity. Thromb Haemost 97: 478-486.
22. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, et al. (2003) Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. Journal of the American Society of Nephrology: JASN 14: 2534-43 Available:http://www.ncbi.nlm.nih.gov/pubmed/14514731.
23. Bonventre JV, (2008) Kidney Injury Molecule-1 (KIM-1): a specific and sensitive biomarker of kidney injury. Scandinavian journal of clinical and laboratory investigation. Supplementum 241: 78-83 doi:10.1080/00365510802145059.
24. Teoh NC, Ito Y, Field J, Bethea NW, Amr D, et al. (2007) Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice. Gastroenterology 133: 632-646.
25. Shen XD, Ke B, Zhai Y, Tsuchihashi SI, Gao F, et al. (2007) Diannexin, a novel annexin v homodimer, protects rat liver transplants against cold ischemia-reperfusion injury. Am J Transplant 7: 2463-2471.
26. Cheng EY, Sharma VK, Chang C, Ding R, Allison AC, et al. (2010) Diannexin decreases inflammatory cell infiltration into the islet graft, reduces β-cell apoptosis, and improves early graft function. Transplantation 90: 709-16 Available:http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2948074&tool=pmcentrez&rendertype=abstract. Accessed 11 Mar 2011.
27. Molski M, Groth A, Allison A, Hendrickson M, Siemionow M, (2009) Diannexin treatment decreases ischemia-reperfusion injury at the endothelial cell level of the microvascular bed in muscle flaps. Annals of plastic surgery 63: 564-71 Available:http://www.ncbi.nlm.nih.gov/pubmed/19806047. Accessed 25 Jun 2010.
28. Facio FN, Sena AA, Araújo LP, Mendes GE, Castro I, et al. (2010) Annexin 1 mimetic peptide protects against renal ischemia/reperfusion injury in rats. Journal of molecular medicine(Berlin, Germany) 89: 51-63 Available:http://www.ncbi.nlm.nih.gov/pubmed/20953576. Accessed 23 Nov 2010.
29. Kenis H, Genderen H van, Bennaghmouch A, Rinia HA, Frederik P, et al. (2004) Cell Surface-expressed Phosphatidylserine and Annexin A5 Open a Novel Portal of Cell Entry. J Biol Chem 279: 52623-52629 Available:http://www.jbc.org/cgi/content/abstract/279/50/52623.
30. Eisner C, Faulhaber-Walter R, Wang Y, Leelahavanichkul A, Yuen PST, et al. (2010) Major contribution of tubular secretion to creatinine clearance in mice. Kidney international 77: 519-26 Available:http://www.ncbi.nlm.nih.gov/pubmed/20032962.
31. Ichimura T, Asseldonk EJPV, Humphreys BD, Gunaratnam L, Duffield JS, et al. (2008) Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. The Journal of clinical investigation 118: 1657-68 doi:10.1172/JCI34487.
32. Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, et al. (1999) Imaging of Apoptosis (Programmed Cell Death) with 99mTc Annexin V. The Journal of Nuclear Medicine 40.
33. Kemerink GJ, Liu X, Kieffer D, Ceyssens S, Mortelmans L, et al. (2003) Safety, Biodistribution, and Dosimetry of 99mTc-HYNIC-Annexin V, a Novel Human Recombinant Annexin V for Human Application. The Journal of Nuclear Medicine 44.
34. Blankenberg F, (2002) To scan or not to scan, it is a question of timing: technetium-99m-annexin V radionuclide imaging assessment of treatment efficacy after one course of chemotherapy. Clinical cancer research: an official journal of the American Association for Cancer Research 8: 2757-8 Available:http://www.ncbi.nlm.nih.gov/pubmed/12231512. Accessed 2 Aug 2011.
35. Zhang R, Lu W, Wen X, Huang M, Zhou M, et al. (2011) Annexin A5-conjugated polymeric micelles for dual SPECT and optical detection of apoptosis. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 52: 958-64 Available:http://www.ncbi.nlm.nih.gov/pubmed/21571801. Accessed 2 Aug 2011.
36. Boersma H, Kietselaer BLJH, Stolk LML, Bennaghmouch A, Hofstra L, et al. (2005) Past, present, and future of annexin A5: from protein discovery to clinical applications. Journal of nuclear medicine 46: 2035-50.
37. Meers P, Daleke D, Hong K, Papahadjopoulos D, (1991) Interactions of annexins with membrane phospholipids. Biochemistry 30: 2903-8.
38. Ramchandran T, Margouleff D, Atkins H, (1980) Spleen scanning in humans with Tc-99m-labeled erythrocytes: concise communication. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 21: 13-6 Available:http://www.ncbi.nlm.nih.gov/pubmed/7356734. Accessed 9 Jun 2011.
39. Huls M, van Den HeuvelJJ, Dijkman HB, Russel FG, Masereeuw R, (2006) ABC transporter expression profiling after ischemic reperfusion injury in mouse kidney. Kidney Int 69: 2186-2193.